Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Corcept Therapeutics (CORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 2,085,426
  • Shares Outstanding, K 113,400
  • Annual Sales, $ 81,320 K
  • Annual Income, $ 8,140 K
  • 36-Month Beta 2.12
  • Price/Sales 25.52
  • Price/Cash Flow 246.59
  • Price/Book 31.32

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.05 +19.28%
on 10/10/17
20.77 -7.82%
on 10/05/17
+0.94 (+5.19%)
since 09/22/17
3-Month
11.88 +61.15%
on 07/28/17
20.77 -7.82%
on 10/05/17
+6.18 (+47.61%)
since 07/21/17
52-Week
6.68 +186.60%
on 10/28/16
20.77 -7.82%
on 10/05/17
+12.20 (+175.86%)
since 10/21/16

Most Recent Stories

More News
Today's Research Reports on Trending Tickers: Corcept Therapeutics and Orexigen Therapeutics

NEW YORK, NY / ACCESSWIRE / October 16, 2017 / U.S. markets rose Friday to close the week in the green as investors appear to be expecting a strong earnings season. The Dow Jones Industrial Average gained...

CORT : 19.11 (+3.92%)
OREX : 1.71 (-3.93%)
Dow Returns to All-Time Highs

Dow Returns to All-Time Highs

CORT : 19.11 (+3.92%)
TX : 31.87 (+0.16%)
COP : 50.37 (+0.24%)
ACRX : 2.05 (+2.50%)
ALR : 50.99 (unch)
DGI : 34.40 (+0.73%)
BBRY : 11.57 (+0.70%)
LBTYA : 31.29 (-1.07%)
High Beta ETFs & Stocks for Market-Beating Returns

High beta stocks & ETFs seek to capitalize on continued growth with market-beating returns.

CORT : 19.11 (+3.92%)
SBIO : 30.81 (-1.00%)
XLY : 91.20 (-0.18%)
FEX : 56.32 (+0.09%)
HUBS : 85.30 (+0.18%)
QHC : 5.16 (+2.99%)
MTOR : 26.21 (-1.02%)
ONEQ : 260.17 (-0.16%)
FDM : 47.32 (-0.25%)
ON : 20.11 (+0.20%)
High Beta ETFs & Stocks for Market-Beating Returns

High beta stocks & ETFs seek to capitalize on continued growth with market-beating returns.

CORT : 19.11 (+3.92%)
SBIO : 30.81 (-1.00%)
XLY : 91.20 (-0.18%)
FEX : 56.32 (+0.09%)
HUBS : 85.30 (+0.18%)
QHC : 5.16 (+2.99%)
MTOR : 26.21 (-1.02%)
ONEQ : 260.17 (-0.16%)
FDM : 47.32 (-0.25%)
ON : 20.11 (+0.20%)
4 Biotech Stocks That Show Promise on Sustainable Growth

Biotech sector is performing well in 2017 due to an increase in FDA approvals, new product sales ramp up, R&D success and innovation, strong clinical study results and continued strong performance of legacy...

SGMO : 13.95 (+3.72%)
HSKA : 96.84 (+0.76%)
CORT : 19.11 (+3.92%)
LLY : 87.72 (+0.56%)
HLUYY : 60.4700 (-0.28%)
GILD : 80.69 (-0.64%)
KITE : 179.99 (+0.11%)
ALXN : 136.00 (-2.17%)
7 Buy-Ranked Stocks That Just Touched New All-Time Highs

42 different stocks hit new all-time highs on Wednesday morning. Check out these seven buy-ranked stocks that just hit all-time highs today!

AYX : 22.13 (+0.36%)
CORT : 19.11 (+3.92%)
ANET : 193.18 (+0.78%)
AVAV : 52.07 (-1.10%)
FOXF : 42.90 (-2.94%)
CAT : 132.07 (+0.54%)
ALRM : 48.00 (+0.19%)
Pfizer's sNDA for Bosulif Accepted in the U.S. and Europe

Pfizer (PFE) along with Avillion announced that the regulatory authorities in the U.S. and Europe have accepted the application for label expansion of Bosulif to include newly diagnosed patients.

CORT : 19.11 (+3.92%)
NVS : 86.15 (+0.48%)
PFE : 36.53 (+0.30%)
BMY : 64.34 (-0.12%)
Top Ranked Momentum Stocks to Buy for August 29th

Top Ranked Momentum Stocks to Buy for August 29th

CORT : 19.11 (+3.92%)
FIVE : 57.46 (-0.05%)
HD : 165.33 (+1.16%)
TGB : 2.18 (-2.24%)
Mylan and Otsuka Ink Agreement to Commercialize Deltyba

Mylan (MYL) and Otsuka Pharmaceutical have entered into a license agreement to commercialize Deltyba in developing countries.

CORT : 19.11 (+3.92%)
MYL : 38.61 (+0.26%)
NVS : 86.15 (+0.48%)
GSK : 40.73 (-0.27%)
Adamas (ADMS) Dyskinesia Drug Gets FDA Approval, Stock Soars

Adamas Pharmaceuticals' (ADMS) Gocovri was approved by the FDA for treating dyskinesia in patients with Parkinson's disease. This led to an upside in shares.

CORT : 19.11 (+3.92%)
ADMS : 18.77 (-2.54%)
ACAD : 36.29 (-0.08%)
REPH : 8.91 (-0.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol....

See More

Support & Resistance

2nd Resistance Point 18.78
1st Resistance Point 18.58
Last Price 19.22
1st Support Level 18.22
2nd Support Level 18.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart